The possible discrepancy of the results of XPG polymorphisms in clinical outcome of NSCLC receiving platinum-based chemotherapy may be due to different backgrounds of cases, sample size, sample size and etc. The gene discussed is ERCC5; the disease is non-small cell lung carcinoma.